Updates
Reply letter-submission of Financial Results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for June 2017.27-09-2017
27-09-2017
Orchid Pharma surges on favourable inspection report
Shares of Orchid Pharma surged as the company has got favourable USFDA inspection report for the facility. The stock jumped by its daily limit of 19.9 per cent to Rs 21.35, highest since August...21-09-2017
Press Release / Media Release
ORCHID HAS RECEIVED THE ESTABLISHMENT INSPECTION REPORT(EIR) FROM USFDA21-09-2017
Outcome of AGM
VOTING RESULTS OF THE 24TH ANNUAL GENERAL MEETING IN THE REVISED FORMAT AS SPECIFIED IN THE SEBI CIRCULAR CIR/CFD/CMD/8/2015 DATED NOVEMBER 04,201518-09-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Orchid Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here16-09-2017
Scrutinizer's Report
OUTCOME OF THE 24TH ANNUAL GENERAL MEETING- DISCLOSURE OF VOTING RESULTS PURSUNAT TO REGULATION 44 (3) OF THE SEBI(LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS,2015 AND THE SCRUTINIZERS REPORT15-09-2017
Meeting Updates
24th Annual General Meeting - Communication from the Interim Resolution Professional(IRP)12-09-2017